The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Use of immunosuppression and subsequent cancer incidence: cohort study
|
|---|---|
| Published in |
BMJ Oncology, August 2023
|
| DOI | 10.1136/bmjonc-2023-000037 |
| Authors |
Jeanine M Buchanich, Craig W Newcomb, Terri L Washington, Charles Stephen Foster, Lucia Sobrin, Jennifer E Thorne, Douglas Alan Jabs, Eric B Suhler, James T Rosenbaum, Hatice Nida Sen, Grace A Levy-Clarke, Robert B Nussenblatt, Nirali P Bhatt, Careen Y Lowder, Debra A Goldstein, Yannek I Leiderman, Nisha R Acharya, Gary N Holland, Russell W Read, James P Dunn, Kurt A Dreger, Pichaporn Artornsombudh, Hosne A Begum, Tonetta D Fitzgerald, Srishti Kothari, Abhishek R Payal, Ebenezer Daniel, Sapna S Gangaputra, Roje Oktay Kaçmaz, Teresa L Liesegang, Siddharth S Pujari, Naira Khachatryan, Armin Maghsoudlou, Hilkiah K Suga, Clara M Pak, Kathy J Helzlsouer, John H Kempen |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 6% |
| Unknown | 16 | 94% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 59% |
| Practitioners (doctors, other healthcare professionals) | 4 | 24% |
| Scientists | 3 | 18% |
Mendeley readers
The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 5 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 2 | 40% |
| Other | 1 | 20% |
| Unknown | 2 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 1 | 20% |
| Agricultural and Biological Sciences | 1 | 20% |
| Medicine and Dentistry | 1 | 20% |
| Unknown | 2 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 190. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2024.
All research outputs
#218,710
of 26,179,045 outputs
Outputs from BMJ Oncology
#5
of 75 outputs
Outputs of similar age
#4,177
of 363,597 outputs
Outputs of similar age from BMJ Oncology
#4
of 11 outputs
Altmetric has tracked 26,179,045 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 75 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 57.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,597 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.